German genetic diagnostics firm Centogene has raised $28 million in a funding round led by TVM Capital Life Science, and featuring participation from Careventures, CIC Capital and DPE Deutsche Private Equity. Centogene, which is compiling a database of rare disease genotypes and phenotypes by conducting tests all over the world, has also taken on a investment consortium to further its expansion ambitions in countries including the US and China.
German genetic diagnostics firm Centogene has raised $28m in a funding round led by TVM Capital Life Science, and featuring participation from Careventures, CIC Capital and DPE Deutsche Private Equity. Centogene, which is compiling a database of rare disease genotypes and phenotypes by conducting tests all over the world, has also taken on a investment consortium to further its expansion ambitions in countries including the US and China.